Increased prevalence of leukocytes and elevated cytokine levels in semen from Schistosoma haematobium-infected individuals

Journal of Infectious Diseases

Volumn 191, Issue 10, 2005, Pages 1639-1647

  Leutscher, Peter D C ^a,b,e   Pedersen, Mette ^b   Raharisolo, Clairette ^a   Jensen, Jørgen Skov ^c   Hoffmann, Steen ^c   Lisse, Ida ^d   Ostrowski, Sisse R ^b   Reimert, Claus M ^b   Mauclere, Philippe ^a   Ullum, Henrik ^b  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b Rigshospitalet   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d STATENS SERUM INSTITUT   (Denmark)

^e DANISH BILHARZIASIS LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISCHISTOSOMAL AGENT; AZITHROMYCIN; CIPROFLOXACIN; DOXYCYCLINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; METRONIDAZOLE; PRAZIQUANTEL; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LEUKOCYTE; MADAGASCAR; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA GENITALIUM; NEISSERIA GONORRHOEAE; PELVIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SEXUALLY TRANSMITTED DISEASE; SPERM DONOR; TRICHOMONAS VAGINALIS; UROGENITAL SYSTEM; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANIMALS; CYTOKINES; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; SCHISTOSOMIASIS HAEMATOBIA; SEMEN; SEXUALLY TRANSMITTED DISEASES;

EID: 20844438684     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/429334     Document Type: Article

References (53)

1. Quinn TC. Global burden of the HIV pandemic. Lancet 1996; 348: 99-106.
2. Clerici M, Giorgi JV, Chou C-C, et al. Cell-mediated immune response to human immunodefiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992; 165:1012-9.
3. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2:1240-3.
4. Dyer JR, Kazembe P, Vernazza PL, et al. High levels of human immunodeficiency virus type 1 in blood and semen in seropositive men in sub-Saharan Africa. J Infect Dis 1998; 177:1742-6.
5. Rizzardini G, Piconi R, Ruzzante S, et al. Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals. AIDS 1996; 10:1535-42.
6. Wasserheit JN. Epidemiological synergy: interrelations between human deficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19:61-77.
7. Dickerson MC, Johnston J, Delea TE, White A, Andrews E. The causal role of genital ulcer diseases as a risk factor for transmission of human immunodeficiency virus: an application of the Bradford Hill Criteria. Sex Transm Dis 1996; 23:429-40.
8. Anzala AO, Simonsen JN, Kimani J, et al. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. J Infect Dis 2000; 182:459-66.
9. Nkengasong JN, Kestens L, Ghys PD, et al. Human immunodefiency virus type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with sexually transmitted diseases in Adidjan, Cote d'Ivoire. J Infect Dis 2001; 183:1405-8.
10. Fang G, Burger H, Grimson R, et al. Maternal plasma human immunodefiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995; 92:12100-4.
11. Busch MP, Operskalski EA, Mosley JW, et al. Factors influencing human immunodefiency virus type 1 transmission by blood transfusion. J Infect Dis 1996; 174:26-33.
12. Lee T-H, Skahara N, Fiebig E, Busch MP, O'Brien TR, Herman SA. Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:427-8.
13. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349:1868-73.
14. Ramsey KH, Schneider H, Cross AS, et al. Inflammatory cytokines produced in response to experimental human gonorrhea. J Infect Dis 1995; 172:186-91.
15. Fichorova RN, Desai PJ, Gibson FC 3rd, Genco CA. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect Immun 2001; 69:5840-8.
16. Maisey K, Nardocci G, Imarai M, et al. Expression of pro-inflammatory cytokines and receptors by human fallopian tubes in organ culture following challenge with Neisseria gonnorrhoeae. Infect Immun 2003; 71:527-32.
17. Leutscher P, Ramarokoto CE, Reimert C, Feldmeier H, Esterre P, Vennervald BJ. Community-based study of genital schistosomiasis in men from Madagascar. Lancet 2000; 355:117-8.
18. Gelfand M, Ross CM, Blair DM, Castle WM, Weber MC. Schistosomiasis of the male pelvic organs: severity of infection as determined by digestion of tissue and histologic methods in 300 cadavers. Am J Trop Med Hyg 1970; 19:779-84.
19. Smith JH, Kamel IA, Elwi A, Von Lichtenberg FA. Quantitative post mortem analysis of urinary schistosomiasis in Egypt. I. Pathology and pathogenesis. Am J Trop Med Hyg 1974; 23:1054-71.
20. Patil PS, Elem B. Schistosomiasis of the prostate and the seminal vesicles: observations in Zambia. J Trop Med Hyg 1988; 91:245-8.
21. Feldmeier H, Poggensee G, Krantz I, Helling-Giese G. Female schistosomiasis as a risk factor for HIV transmission. Int J STD AIDS 1994; 5: 368-72.
22. Makler A. A new chamber for rapid sperm count and motility estimation. Fertil Steril 1978; 30:313-8.
23. Chen R, Lowe L, Wilson JD, et al. Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology. Clin Chem 1999; 45:1693-1.
24. Wolff H, Anderson DJ. Male genital tract inflammation is associated with increased numbers of potential human immunodeficiency virus host cells in semen. Andrologia 1988; 20:404-10.
25. Lucey DR, Nicholson-Weller A, Weller PF. Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp 120. J Exp Med 1989; 169:327-32.
26. Rubbert A, Combadiere C, Ostrowski M, et al. Dendritic cells express multiple chemokine receptors used as co-receptors for HIV entry. J Immunol 1998; 160:3933-11.
27. Conway B, Baskar P, Bechtel LJ, et al. Eosinophils as host cells for HIV-1. Arch Virol 1992; 127:373-7.
28. Freedman AR, Gibson FM, Flemming SC, Spry CJ, Griffin GE. Human immunodeficiency virus infection of eosinophil leucocytes in human bone marrow cultures. J Exp Med 1991; 174:1661-1.
29. Weller PF, Marshall WL, Lucey DR, Rand TH, Dvorak AM, Finberg RW. Infection, apoptosis, killing of mature human eosinophiles by human immunodeficiency virus-1. Am J Respir Cell Mol Biol 1995; 13:610-20.
30. Reimert CM, Ouma JH, Mwanja MT, et al. Indirect assessment of eosinophiluria in urinary schistosomiasis using eosinophil cationicprotein (ECP) and eosinophil protein X (EPX). Acta Trop 1993; 54:1-12.
31. Yazdanbakhsh M. Common features of T cell reactivity in persistent helminth infections: lymphatic filariasis and schistosomiais. Immunol Lett 1999; 65:109-15.
32. Dessein AJ, Hillaire D, Elwali NE, et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-7 receptor gene. Am J Hum Genet 1999; 65:709-21.
33. Mduluza T, Ndhlovu PD, Midzi N, et al. T cell clones from Schistosoma haematobium infected and exposed individuals lacking distinct profiles for Th1/Th2 polarisation. Mem Inst Oswaldo Cruz 2001; 96(Suppl): 89-101.
34. El Ridi R, Ismail S, Gaafar T, El Demellawy M. Differential responsiveness of humans with early-stage schistosomiasis haematobium to Schistosoma haematobium soluble adult-worm and egg antigens. Parasitol Res 1997; 83:471-7.
35. Amiri P, Locksley RM, Parslow TG, et al. Tumour necrosis factor α restores granulomas and induces parasite egg-laying in schistosome SCID mice. Nature 1992; 356:604-7.
36. Wynn TA, Cheever AW. Cytokine regulation of granuloma formation in schistosomiasis. Curr Opin Immunol 1995; 7:505-11.
37. King CL, Malhotra I, Mungai P, et al. Schistosoma haematobium-induced urinary tract morbidity correlates with increased tumor necrosis factor-α and diminished interleukin-10 production. J Infect Dis 2001; 184:1176-82.
38. Henri S, Chevillard C, Mergani A, et al. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-γ is associated with protection against fibrosis and TNF-α with aggravation of disease. J Immunol 2002; 169:929-36.
39. McGhee JR, Mestecky J, Elson CO, Kiyono H. Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol 1989; 9:175-99.
40. Kedzierska K, Crowe SM. Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother 2001; 12:133-50.
41. Kedzierska K, Crowe SM, Turville S, Cunningham AL. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev Med Virol 2003; 13:39-56.
42. Ho JL, He S, Hu A, et al. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. J Exp Med 1995; 181:1493-505.
43. Rosenberg ZF, Fauci AS. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today 1990; 11:176-80.
44. Bentwitch Z, Kalinkowich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995; 16:187-91.
45. Wolday D, Berhe N, Akuffo H, Britton S. Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol Today 1999; 15:182-7.
46. Harms G, Feldmeier H. HIV infection and tropical parasitic diseases - deleterious interactions in both directions? Trop Med Int Health 2002; 7:479-88.
47. Lawn SD, Karanja DM, Mwinzia P, et al. The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in co-infected individuals. AIDS 2000; 14:2437-43.
48. Elliott AM, Mawa PW, Joseph S, et al. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Uganda adults. Trans R Soc Trop Med Hyg 2003; 97: 103-8.
49. Fontanet AL, Woldemichael T, Sahlu T, et al. Epidemiology of HIV and Schistosoma mansoni infections among sugar-estate residents in Ethiopia. Ann Trop Med Parasitol 2000; 94:145-55.
50. Mwinzi PN, Karanja DM, Colley DG, et al. Cellular immune response of schistosomiasis patients are altered by human immunodefiency virus type 1 coinfection. J Infect Dis 2001; 184:488-96.
51. Karanja DM, Hightower AW, Colley DG, et al. Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study. Lancet 2002; 360:592-6.
52. Karanja DM, Boyer AE, Strand M, et al. Studies on schistosomiasis in western Kenya. II. Efficacy of praziquantel for treatment of schistosomiaisis in persons coinfected with human immunodeficiency virus-1. Am J Trop Med Hyg 1998; 59:307-11.
53. Serieye J, Boisier P, Ravaolimalala VE, et al. Schistosoma haematobium infection in western Madagascar: morbidity determined by ultrasonography. Trans R Soc Trop Med Hyg 1996; 90:398-401.